Salvia BioElectronics receives FDA Breakthrough Device Designation for innovative neurostimulation solution



Comments are closed.

Cortexyme Completes $76 Million Series B Financing
Digilens Series D led by Samsung Electronics
Dolby Family Ventures Works with Keyssa in Stealth Mode
MedaRed Raises $6.5 Million and Appoints Industry Leaders to Board of Directors, Top Management Roles